The influence of menopause status and postmenopausal use of hormone therapy on presentation of major depression in women

Susan G. Kornstein, Elizabeth A. Young, Annie T. Harvey, Stephen R. Wisniewski, Jennifer L. Barkin, Michael E. Thase, Madhukar H. Trivedi, Andrew A. Nierenberg, A. John Rush

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Objective: The purpose of this study was to determine whether there are differences in depression characteristics among premenopausal, perimenopausal, and postmenopausal women with major depressive disorder. This study also evaluated these differences between postmenopausal women with major depressive disorder who are taking and not taking hormone therapy. Methods: Analyses conducted with data from the Sequenced Treatment Alternatives to Relieve Depression study focused on female outpatients with nonpsychotic major depressive disorder seeking treatment in 41 primary or psychiatric care settings across the United States. Baseline demographic and clinical characteristics were compared among women not taking hormone therapy who were premenopausal (n = 950), perimenopausal (n = 380), or postmenopausal (n = 562). These comparisons were also made between postmenopausal women (n = 768) taking (n = 171) or not taking (n = 562) hormone therapy. Results: After adjusting for sociodemographic and clinical baseline differences, premenopausal women were more likely to present with irritability than were either perimenopausal or postmenopausal women and were more likely to have decreased appetite and less likely to have early-morning insomnia than were perimenopausal women. Postmenopausal women were more likely to have suicidal ideation and poorer physical functioning than were either of the other groups and were more likely to have sympathetic arousal and gastrointestinal symptoms than were premenopausal women. After adjusting for baseline differences, postmenopausal women taking hormone therapy had better physical functioning, fewer melancholic features, less sympathetic arousal, and more lack of involvement in activities than did women not taking hormone therapy. Conclusions: Menopause status and postmenopausal use of hormone therapy may influence the clinical presentation of major depressive episodes in women.

Original languageEnglish (US)
Pages (from-to)828-839
Number of pages12
JournalMenopause
Volume17
Issue number4
DOIs
StatePublished - 2010

Fingerprint

Menopause
Hormones
Depression
Major Depressive Disorder
Therapeutics
Arousal
Suicidal Ideation
Sleep Initiation and Maintenance Disorders
Appetite
Psychiatry
Outpatients
Demography

Keywords

  • Depression
  • Hormone therapy
  • Major depressive disorder
  • Menopause

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Medicine(all)

Cite this

Kornstein, S. G., Young, E. A., Harvey, A. T., Wisniewski, S. R., Barkin, J. L., Thase, M. E., ... Rush, A. J. (2010). The influence of menopause status and postmenopausal use of hormone therapy on presentation of major depression in women. Menopause, 17(4), 828-839. https://doi.org/10.1097/gme.0b013e3181d770a8

The influence of menopause status and postmenopausal use of hormone therapy on presentation of major depression in women. / Kornstein, Susan G.; Young, Elizabeth A.; Harvey, Annie T.; Wisniewski, Stephen R.; Barkin, Jennifer L.; Thase, Michael E.; Trivedi, Madhukar H.; Nierenberg, Andrew A.; Rush, A. John.

In: Menopause, Vol. 17, No. 4, 2010, p. 828-839.

Research output: Contribution to journalArticle

Kornstein, SG, Young, EA, Harvey, AT, Wisniewski, SR, Barkin, JL, Thase, ME, Trivedi, MH, Nierenberg, AA & Rush, AJ 2010, 'The influence of menopause status and postmenopausal use of hormone therapy on presentation of major depression in women', Menopause, vol. 17, no. 4, pp. 828-839. https://doi.org/10.1097/gme.0b013e3181d770a8
Kornstein, Susan G. ; Young, Elizabeth A. ; Harvey, Annie T. ; Wisniewski, Stephen R. ; Barkin, Jennifer L. ; Thase, Michael E. ; Trivedi, Madhukar H. ; Nierenberg, Andrew A. ; Rush, A. John. / The influence of menopause status and postmenopausal use of hormone therapy on presentation of major depression in women. In: Menopause. 2010 ; Vol. 17, No. 4. pp. 828-839.
@article{0a49421fb9b64d148d5c9c09f8366e92,
title = "The influence of menopause status and postmenopausal use of hormone therapy on presentation of major depression in women",
abstract = "Objective: The purpose of this study was to determine whether there are differences in depression characteristics among premenopausal, perimenopausal, and postmenopausal women with major depressive disorder. This study also evaluated these differences between postmenopausal women with major depressive disorder who are taking and not taking hormone therapy. Methods: Analyses conducted with data from the Sequenced Treatment Alternatives to Relieve Depression study focused on female outpatients with nonpsychotic major depressive disorder seeking treatment in 41 primary or psychiatric care settings across the United States. Baseline demographic and clinical characteristics were compared among women not taking hormone therapy who were premenopausal (n = 950), perimenopausal (n = 380), or postmenopausal (n = 562). These comparisons were also made between postmenopausal women (n = 768) taking (n = 171) or not taking (n = 562) hormone therapy. Results: After adjusting for sociodemographic and clinical baseline differences, premenopausal women were more likely to present with irritability than were either perimenopausal or postmenopausal women and were more likely to have decreased appetite and less likely to have early-morning insomnia than were perimenopausal women. Postmenopausal women were more likely to have suicidal ideation and poorer physical functioning than were either of the other groups and were more likely to have sympathetic arousal and gastrointestinal symptoms than were premenopausal women. After adjusting for baseline differences, postmenopausal women taking hormone therapy had better physical functioning, fewer melancholic features, less sympathetic arousal, and more lack of involvement in activities than did women not taking hormone therapy. Conclusions: Menopause status and postmenopausal use of hormone therapy may influence the clinical presentation of major depressive episodes in women.",
keywords = "Depression, Hormone therapy, Major depressive disorder, Menopause",
author = "Kornstein, {Susan G.} and Young, {Elizabeth A.} and Harvey, {Annie T.} and Wisniewski, {Stephen R.} and Barkin, {Jennifer L.} and Thase, {Michael E.} and Trivedi, {Madhukar H.} and Nierenberg, {Andrew A.} and Rush, {A. John}",
year = "2010",
doi = "10.1097/gme.0b013e3181d770a8",
language = "English (US)",
volume = "17",
pages = "828--839",
journal = "Menopause",
issn = "1072-3714",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - The influence of menopause status and postmenopausal use of hormone therapy on presentation of major depression in women

AU - Kornstein, Susan G.

AU - Young, Elizabeth A.

AU - Harvey, Annie T.

AU - Wisniewski, Stephen R.

AU - Barkin, Jennifer L.

AU - Thase, Michael E.

AU - Trivedi, Madhukar H.

AU - Nierenberg, Andrew A.

AU - Rush, A. John

PY - 2010

Y1 - 2010

N2 - Objective: The purpose of this study was to determine whether there are differences in depression characteristics among premenopausal, perimenopausal, and postmenopausal women with major depressive disorder. This study also evaluated these differences between postmenopausal women with major depressive disorder who are taking and not taking hormone therapy. Methods: Analyses conducted with data from the Sequenced Treatment Alternatives to Relieve Depression study focused on female outpatients with nonpsychotic major depressive disorder seeking treatment in 41 primary or psychiatric care settings across the United States. Baseline demographic and clinical characteristics were compared among women not taking hormone therapy who were premenopausal (n = 950), perimenopausal (n = 380), or postmenopausal (n = 562). These comparisons were also made between postmenopausal women (n = 768) taking (n = 171) or not taking (n = 562) hormone therapy. Results: After adjusting for sociodemographic and clinical baseline differences, premenopausal women were more likely to present with irritability than were either perimenopausal or postmenopausal women and were more likely to have decreased appetite and less likely to have early-morning insomnia than were perimenopausal women. Postmenopausal women were more likely to have suicidal ideation and poorer physical functioning than were either of the other groups and were more likely to have sympathetic arousal and gastrointestinal symptoms than were premenopausal women. After adjusting for baseline differences, postmenopausal women taking hormone therapy had better physical functioning, fewer melancholic features, less sympathetic arousal, and more lack of involvement in activities than did women not taking hormone therapy. Conclusions: Menopause status and postmenopausal use of hormone therapy may influence the clinical presentation of major depressive episodes in women.

AB - Objective: The purpose of this study was to determine whether there are differences in depression characteristics among premenopausal, perimenopausal, and postmenopausal women with major depressive disorder. This study also evaluated these differences between postmenopausal women with major depressive disorder who are taking and not taking hormone therapy. Methods: Analyses conducted with data from the Sequenced Treatment Alternatives to Relieve Depression study focused on female outpatients with nonpsychotic major depressive disorder seeking treatment in 41 primary or psychiatric care settings across the United States. Baseline demographic and clinical characteristics were compared among women not taking hormone therapy who were premenopausal (n = 950), perimenopausal (n = 380), or postmenopausal (n = 562). These comparisons were also made between postmenopausal women (n = 768) taking (n = 171) or not taking (n = 562) hormone therapy. Results: After adjusting for sociodemographic and clinical baseline differences, premenopausal women were more likely to present with irritability than were either perimenopausal or postmenopausal women and were more likely to have decreased appetite and less likely to have early-morning insomnia than were perimenopausal women. Postmenopausal women were more likely to have suicidal ideation and poorer physical functioning than were either of the other groups and were more likely to have sympathetic arousal and gastrointestinal symptoms than were premenopausal women. After adjusting for baseline differences, postmenopausal women taking hormone therapy had better physical functioning, fewer melancholic features, less sympathetic arousal, and more lack of involvement in activities than did women not taking hormone therapy. Conclusions: Menopause status and postmenopausal use of hormone therapy may influence the clinical presentation of major depressive episodes in women.

KW - Depression

KW - Hormone therapy

KW - Major depressive disorder

KW - Menopause

UR - http://www.scopus.com/inward/record.url?scp=77954900225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954900225&partnerID=8YFLogxK

U2 - 10.1097/gme.0b013e3181d770a8

DO - 10.1097/gme.0b013e3181d770a8

M3 - Article

C2 - 20616669

AN - SCOPUS:77954900225

VL - 17

SP - 828

EP - 839

JO - Menopause

JF - Menopause

SN - 1072-3714

IS - 4

ER -